Nurx Stock
Nurx is an on-demand birth control delivery company that prescribes contraceptives through its app.
About Nurx Stock
Nurx eliminate the hassle of obtaining select prescription medications. By answering a few simple questions, a doctor in their network can write a prescription and they can send the drugs out by courier. The whole process from first tap to delivery typically takes less than 90 minutes. They are starting with a few easy-to-prescribe drugs, such as contraceptives, Truvada for PrEP and travel medications.
Funding History
| November 2015 | $120K |
|---|---|
| October 2016 | $5.3M |
Management
Founder
Edvard Engesæth
Co-Founder & Chief Executive Officer
Hans Gangeskar
Press
Birth control delivery startup Nurx introduces STI home-testing kits
TechCrunch - Jul, 10 2019
Birth control delivery startup Nurx taps Clover Health’s Varsha Rao as CEO
TechCrunch - Apr, 16 2019
Birth control delivery startup Nurx now offers an at-home HPV testing kit
TechCrunch - Dec, 4 2018
Nurx raises $36 million and adds Chelsea Clinton to its board of directors
TechCrunch - Jul, 11 2018
Birth control app Nurx now delivers to the ‘contraceptive deserts’ of Texas
TechCrunch - Jun, 5 2017
Other Companies
Freenome
Freenome is a platform that helps design healthy conditions for an individual based on his/her cell-free genome
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Nurx or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
